United States · Funded startup

Who invested in CymaBay Therapeutics

8 rounds we have observed, with the 24 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$172Mraised across 8 rounds since 2003, from 8 sources

$27MVenture$44MSeries B$32MSeries D$28MDebt$8.6MVenture$27MVenture$5.0MDebt$325KDebt
Latest round
Debt, $325KAug 2015
Biggest round
$44MSeries B · Dec 2004
Investors
24
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2003200520072009201120132015
$27MVenture$44MSeries B$32MSeries D$28MDebt$8.6MVenture$27MVenture$5.0MDebt$325KDebt
First round
Venture, $27M
Aug 2003
Biggest round
$44M
Series B · Dec 2004
Usual gap between rounds
20 months
the median of 7

The rounds

  1. Aug 2015
    Debt$325K

    No investor was named in the report.

    From a historical funding recordSEC filing: $325K sold, first sale Aug 2015

  2. Dec 2013
    Debt$5.0M2 new

    Reported by bizjournals.comSEC filing: $30M sold, first sale Sept 2013

  3. Oct 2013
    Venture$27M

    No investor was named in the report.

    Reported by sec.govSEC filing: $27M sold, first sale Sept 2013

  4. Nov 2009
  5. Jul 2009
    Debt$28M

    No investor was named in the report.

    From a historical funding record

  6. Apr 2007
  7. Dec 2004
    Series B$44M6 new1 returning

    From a historical funding record

  8. Aug 2003

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Bay City CapitalVC firm4rounds
VenrockVC firm3rounds
Versant VenturesVC firm3rounds
Alta PartnersVC firm3rounds
Birchmere VenturesVC firm3rounds
Novo HoldingsVC firm2rounds
Merlin BiomedGrowth equity2rounds
KBC Private EquityPrivate equity2rounds
Biotech Turnaround Fund (BTF)Growth equity2rounds
SVB CapitalVC firm1round
DeerfieldVC firm1round
MPM CapitalPrivate equity1round
T. Rowe PricePrivate equity1round
Novo Holdings A/SGrowth equity1round
Oxford Finance LLCPrivate equity1round
AllianceBernsteinVC firm1round
KBCGrowth equity1round
Next Chapter HoldingsFamily office1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about CymaBay Therapeutics

Who invested in CymaBay Therapeutics?

CymaBay Therapeutics's investors include Bay City Capital, Venrock, Versant Ventures, Alta Partners and Birchmere Ventures, and 19 more on record.

How much has CymaBay Therapeutics raised?

CymaBay Therapeutics has raised $172M across 8 rounds since 2003.

When did CymaBay Therapeutics last raise?

CymaBay Therapeutics's most recent round was a Debt of $325K in Aug 2015.

What was CymaBay Therapeutics's biggest round?

CymaBay Therapeutics's largest round on record is $44M (Series B), in Dec 2004.

Who backed CymaBay Therapeutics first?

CymaBay Therapeutics's first round on record, in Aug 2003, was backed by Bay City Capital, CDP Capital Technology Ventures and Charter Venture Group and 1 others.

What stage is CymaBay Therapeutics at?

CymaBay Therapeutics's latest named round is a Debt, in Aug 2015.

Where is CymaBay Therapeutics based?

CymaBay Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.